Navigation Links
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Date:9/4/2007

- Results Presented at 12th World Conference on Lung Cancer in Seoul -

SOUTH SAN FRANCISCO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that updated results of its Phase 2 clinical trial of picoplatin confirm and extend the previously announced interim data analysis, which demonstrated a survival benefit in patients with recurrent small cell lung cancer (SCLC) who have relapsed within six months of first-line therapy. The company also for the first time announced the median one-year survival rate of 17.6 percent in the Phase 2 population of mostly platinum-refractory and -resistant patients studied in this trial. Picoplatin, the Company's lead product candidate, is currently being evaluated in the pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial in SCLC, which is being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA). The SPEAR trial is being conducted in platinum-refractory, -resistant, and -sensitive SCLC patients who have failed or relapsed from initial therapy within six months of initial treatment and is comparing picoplatin treatment with best supportive care to best supportive care alone. The median overall survival is approximately 17 to 22 weeks for patients with recurrent SCLC who are treated with existing second-line chemotherapies, according to the 2007 National Comprehensive Cancer Network practice guidelines.

"These updated Phase 2 data are consistent with earlier studies of picoplatin in this difficult-to-treat patient population and compare favorably with the median survival for the entire populatio
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 On August ... Duffey, Jr. , issued a 123-page order in the ... Wright Medical Conserve metal-on-metal hip replacement devices are defective.[1]  ... summary judgment as to Plaintiff Robyn Christiansen,s claims for ... The Court flatly rejected Wright Medical,s claim that the ...
(Date:9/1/2015)... Delaware , United States ... "Company" or "Invion"), is pleased to announce that it has ... an institutional investor in the United States ... approximately A$1.001 million ("Placement") by the issue of 71,500,000 million ... per share. The Company has also agreed ...
(Date:9/1/2015)... 2015 Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... to the Patent Trial and Appeals Board (PTAB) in ... review (IPR), filed by a unit of Boston Scientific Corporation, ... No. 8,359,102 (the ,102 patent). The ,102 patent is one ...
Breaking Medicine Technology:Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2
... Women,s sexual health company, TivaMed, today announced it has ... 2010 launch of its Viveve system to OB/GYNs in select ... captures the essence of our company focus on women,s sexual ... exists for the sole purpose of helping women restore their ...
... Boston Scientific Corporation (NYSE: BSX ) today announced ... (CRT-D) and TELIGEN® implantable cardioverter defibrillator (ICD) in Japan. ... of Health, Labor and Welfare (MHLW) in August and ... are the result of a multi-year research and development ...
Cached Medicine Technology:Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4
(Date:9/2/2015)... ... 2015 , ... On September 9, 2015, over 27,000 people from all over ... convention to date for the state of Utah. , “We are thrilled with the ... David Stirling, doTERRA CEO. “One of the most exciting elements of our convention is ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Brain Aneurysm Awareness Month , which was established by the Foundation in ... awareness and education, and helping fund more research remains our top priority,” commented ...
(Date:9/2/2015)... ... ... Mobile working is increasingly more important, as business professionals are looking to ... are being launched, and mobile device usage as a whole is something people around ... personal lives. What's more people are expecting mobile versions of their favorite software. , ...
(Date:9/1/2015)... ... 2015 , ... September is National Prostate Cancer Awareness Month and Florida Hospital ... each year in the United States. , Prostate cancer is to men what breast ... 1 in 7 men. One new case occurs every 2.3 minutes and a man ...
(Date:9/1/2015)... ... 2015 , ... According to a study published August 25th in ... in a three year study about weight loss and diabetes were far more likely ... loss surgery at the onset of the trial. In fact, the participants in the ...
Breaking Medicine News(10 mins):Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... Veteran,s charity supports Obama administration,s announcement of plan ... system available to wounded veterans , OSSINING, N.Y., ... Salute America,s Heroes , a leading non-partisan, ... veterans returning from Iraq and Afghanistan and their ...
... FRANCISCO, April 9 Burrill & Company, a San ... principal activities in Venture Capital, Private Equity, Merchant Banking ... promotions: , Tiba Aynechi to Director, Merchant Banking ... Patel to Senior Associate, Merchant Banking Tiba Aynechi ...
... previous obesity , , THURSDAY, April 9 (HealthDay News) -- ... at increased risk for physical disabilities, even if they,ve shed ... a new U.S. study. , "In both men and women, ... developing mobility limitations in old age, and the longer they ...
... Legacy Foundation(R) and ASPCA(R) Urge Pet Owners to Safeguard Their ... April 9 The American Legacy Foundation(R) is challenging pet ... of April, which kicks off Prevention of Cruelty to Animals ... safe levels of exposure to secondhand smoke -- for humans ...
... Largest Breast Cancer Organization Investing $60 Million to Research Despite ... Testing whether a powerful ingredient in marijuana can help slow ... of six Bay Area breast cancer studies being funded this ... leader in the breast cancer movement announced today. The projects ...
... touts five of the first 23 recognized facilities.MILWAUKEE, April 9 ... is home to five breast centers out of ... Program for Breast Centers ( NAPBC ), a ... http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b )The first facility named in Wisconsin, was ...
Cached Medicine News:Health News:Coalition to Salute America's Heroes(TM) Applauds President's Announcement to Create Joint Virtual Lifetime Records 2Health News:Burrill & Company Announces Promotions 2Health News:Extra Pounds in Mid-Life Affect Later Mobility 2Health News:Tobacco is Toxic for Toto Too 2Health News:Tobacco is Toxic for Toto Too 3Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 2Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 3Health News:Aurora Health Care Breast Centers Receive National Recognition 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: